Steve Schonfeld’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.1M Buy
+42,742
New +$924K ﹤0.01% 1506
2025
Q3
– Sell
-10,340
Closed -$237K – 2174
2025
Q2
$237K Buy
+10,340
New +$257K ﹤0.01% 1746
2025
Q1
– Sell
-42,614
Closed -$1.58M – 2187
2024
Q4
$1.58M Buy
42,614
+33,007
+344% +$1.51M 0.01% 927
2024
Q3
$466K Sell
9,607
-2,143
-18% -$94K ﹤0.01% 1469
2024
Q2
$470K Buy
11,750
+5,521
+89% +$229K ﹤0.01% 1513
2024
Q1
$274K Buy
+6,229
New +$322K ﹤0.01% 1684
2023
Q1
– Sell
-16,398
Closed -$459K – 2065
2022
Q4
$459K Sell
16,398
-16,502
-50% -$479K ﹤0.01% 1573
2022
Q3
$924K Buy
32,900
+25,100
+322% +$820K 0.01% 1324
2022
Q2
$271K Sell
7,800
-14,700
-65% -$525K ﹤0.01% 1729
2022
Q1
$807K Buy
+22,500
New +$638K 0.01% 1100
2020
Q1
– Sell
-70,179
Closed -$1.35M – 1117
2019
Q4
$1.35M Buy
+70,179
New +$1.35M 0.03% 423
2019
Q3
– Sell
-17,000
Closed -$358K – 1007
2019
Q2
$358K Sell
17,000
-26,500
-61% -$554K 0.01% 729
2019
Q1
$888K Buy
+43,500
New +$975K 0.03% 534
2017
Q1
– Sell
-25,561
Closed -$470K – 585
2016
Q4
$470K Buy
+25,561
New +$497K 0.06% 349

Other funds holding AMPH

Steve Schonfeld's AMPH Position: Q3 2026 in Review

Steve Schonfeld opened a new position in Amphastar Pharmaceuticals (AMPH) in Q3 2026: 42,742 shares worth $1.1M. The stake represents ﹤0.01% of the portfolio and ranks #1506 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in AMPH as recently as Q2 2025.

Steve Schonfeld first reported a position in AMPH in Q4 2016 and has held it in 14 quarters since. The position peaked at $1.58M in Q4 2024. 227 funds tracked by Wall St. Rank hold AMPH as of Q3 2026.

  • Steve Schonfeld held 42,742 shares of Amphastar Pharmaceuticals worth $1.1M as of Q3 2026.
  • Amphastar Pharmaceuticals was a new Steve Schonfeld position in Q3 2026.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Steve Schonfeld's portfolio in Q3 2026, its #1506 holding.
  • Steve Schonfeld first reported a position in Amphastar Pharmaceuticals in Q4 2016 and has held it in 14 quarters since.
  • Steve Schonfeld's Amphastar Pharmaceuticals position peaked at $1.58M in Q4 2024.
  • 227 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.